Shenzhen Kangtai Stock Hits Day High with Strong 3.49% Intraday Surge

Shenzhen Kangtai Biological Products Co., Ltd. has experienced a notable increase of 3.49% on March 27, 2026, reaching an intraday high of CNY 13.93. This performance stands in contrast to the China Shanghai Composite, which rose by 0.63% on the same day. Despite this daily uptick, the company has faced significant challenges over the longer term, with a one-year performance decline of 11.00% compared to the benchmark's gain of 16.01%. The company's market capitalization is CNY 12,826 million, categorizing it as a large-cap entity within the Pharmaceuticals & Biotechnology sector. However, its financial metrics reveal underlying issues, including a return on equity of -1.05% and a staggering P/E ratio of 250.00. Over the past five years, net sales have grown at an annual rate of just 6.51%, while operating profit has plummeted by 179.36%. Shenzhen Kangtai's performance indicators suggest a consistent underperformance against the China Shanghai Composite, raising concerns about its long-term growth prospects.